Spark Therapeutics
Spark Therapeutics is a biotechnology company focused on developing gene therapies for rare genetic diseases. It is pioneering one-time treatments targeting inherited retinal disorders, hemophilia, and neurodegenerative conditions using proprietary AAV vector technology. It is a subsidiary of Roche.
Address: 3737 Market Street, Suite 1300, Philadelphia, PA 19104
Phone: 1‑855‑SPARKTX (855) 772‑7589 or (215) 220-9300
-
Former CHOP CEO, Spark Therapeutics Co-founder To Lead New Biotech Startup After Receiving $54M in Funding
Dr. Steven M. Altschuler, who served 15 years as CEO of The Children’s Hospital of Philadelphia and is the co-founder of Spark Therapeutics, is leading…
-
CHOP Gene Therapy Spinout, Latus Bio, Emerges From Stealth Mode With $54M Investment
The Children’s Hospital of Philadelphia spinoff Latus Bio managed to raise $54 million and has now emerged from stealth mode, writes John George for the…
Founding Partners
Advertisement
Affiliate Partners
